2 Articles
2 Articles
All
Left
Center
1
Right
Biocartis' EGFR Mutation Test gains IVDR Class C CDx certification
Biocartis’ Idylla EGFR Mutation Test has secured the EU Technical Documentation Assessment and Quality Management System certificate, making it the first Idylla Test to achieve Class C companion diagnostic (CDx) in vitro medical device status.The post Biocartis’ EGFR Mutation Test gains IVDR Class C CDx certification appeared first on Medical Device Network.
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center1Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium